PALISADE BIO, INC. Quarterly Net Income (Loss) Attributable to Parent in USD from Q2 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Palisade Bio, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q2 2010 to Q3 2024.
  • Palisade Bio, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$3.49M, a 3.03% increase year-over-year.
  • Palisade Bio, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$14.1M, a 7.79% decline year-over-year.
  • Palisade Bio, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$12.3M, a 13.7% increase from 2022.
  • Palisade Bio, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$14.3M, a 46.4% increase from 2021.
  • Palisade Bio, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$26.6M, a 158% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$14.1M -$3.49M +$109K +3.03% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 -$14.2M -$4.08M -$687K -20.2% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-12
Q1 2024 -$13.5M -$3.53M -$1.19M -50.7% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-13
Q4 2023 -$12.3M -$2.97M +$749K +20.1% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-26
Q3 2023 -$13M -$3.6M +$395K +9.9% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 -$13.4M -$3.39M -$1.05M -44.8% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-12
Q1 2023 -$12.4M -$2.34M +$1.87M +44.4% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-13
Q4 2022 -$14.3M -$3.72M -$4.79M -447% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-26
Q3 2022 -$9.47M -$3.99M -$12.1M -149% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $2.61M -$2.34M +$29.4M +92.6% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 -$26.8M -$4.21M -$175K -4.34% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 -$26.6M $1.07M +$5.32M Oct 1, 2021 Dec 31, 2021 10-K 2023-03-22
Q3 2021 -$31.9M $8.09M +$9.93M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$41.9M -$31.7M -$29.9M -1615% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 -$12M -$4.03M -$1.65M -69% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-13
Q4 2020 -$10.3M -$4.24M -$2.21M -108% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-17
Q3 2020 -$8.12M -$1.84M -$79.9K -4.53% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 -$8.04M -$1.85M -$414K -28.8% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-23
Q1 2020 -$7.62M -$2.38M +$730K +23.4% Jan 1, 2020 Mar 31, 2020 10-Q 2021-08-23
Q4 2019 -$8.35M -$2.04M -$1.72M -536% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-22
Q3 2019 -$6.63M -$1.76M +$67.1K +3.67% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-10
Q2 2019 -$6.7M -$1.44M -$810K -129% Apr 1, 2019 Jun 30, 2019 10-Q 2020-11-10
Q1 2019 -$5.89M -$3.11M -$967K -45% Jan 1, 2019 Mar 31, 2019 10-Q 2020-11-10
Q4 2018 -$4.92M -$320K +$3M +90.3% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-27
Q3 2018 -$7.92M -$1.83M -$1.7M -1268% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-14
Q2 2018 -$6.22M -$627K +$4.02M +86.5% Apr 1, 2018 Jun 30, 2018 10-Q 2019-11-14
Q1 2018 -$10.2M -$2.15M +$5.42M +71.6% Jan 1, 2018 Mar 31, 2018 10-Q 2019-11-14
Q4 2017 -$15.7M -$3.32M +$2.08M +38.6% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-22
Q3 2017 -$17.7M -$134K +$5.09M +97.4% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-14
Q2 2017 -$22.8M -$4.65M -$797K -20.7% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-13
Q1 2017 -$22M -$7.57M -$961K -14.6% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-15
Q4 2016 -$21.1M -$5.4M -$631K -13.2% Oct 1, 2016 Dec 31, 2016 10-K 2018-04-02
Q3 2016 -$20.4M -$5.22M +$417K +7.4% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-08
Q2 2016 -$20.9M -$3.85M +$1.6M +29.3% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-08
Q1 2016 -$22.5M -$6.61M -$1.55M -30.7% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-10
Q4 2015 -$20.9M -$4.77M +$738K +13.4% Oct 1, 2015 Dec 31, 2015 10-K 2016-03-14
Q3 2015 -$21.6M -$5.64M -$1.18M -26.5% Jul 1, 2015 Sep 30, 2015 10-K 2016-03-14
Q2 2015 -$20.5M -$5.45M +$1.3M +19.3% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-11
Q1 2015 -$21.8M -$5.05M +$866K +14.6% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-09
Q4 2014 -$22.6M -$5.5M -$2.2M -66.6% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-14
Q3 2014 -$20.4M -$4.46M +$2.23M +33.4% Jul 1, 2014 Sep 30, 2014 10-K 2016-03-14
Q2 2014 -$22.7M -$6.75M -$500K -7.99% Apr 1, 2014 Jun 30, 2014 10-K 2016-03-14
Q1 2014 -$22.2M -$5.92M -$2.33M -64.9% Jan 1, 2014 Mar 31, 2014 10-K 2016-03-14
Q4 2013 -$19.8M -$3.3M -$588K -21.7% Oct 1, 2013 Dec 31, 2013 10-K 2015-03-16
Q3 2013 -$19.2M -$6.69M -$4.11M -159% Jul 1, 2013 Sep 30, 2013 10-K 2015-03-16
Q2 2013 -$15.1M -$6.25M -$3.88M -163% Apr 1, 2013 Jun 30, 2013 10-K 2015-03-16
Q1 2013 -$11.3M -$3.59M -$1.14M -46.4% Jan 1, 2013 Mar 31, 2013 10-K 2015-03-16
Q4 2012 -$10.1M -$2.71M -$159K -6.2% Oct 1, 2012 Dec 31, 2012 10-K 2014-03-10
Q3 2012 -$9.96M -$2.58M +$634K +19.7% Jul 1, 2012 Sep 30, 2012 10-K 2014-03-10
Q2 2012 -$10.6M -$2.38M +$1.27M +34.9% Apr 1, 2012 Jun 30, 2012 10-K 2014-03-10
Q1 2012 -$11.9M -$2.45M +$649K +20.9% Jan 1, 2012 Mar 31, 2012 10-K 2014-03-10
Q4 2011 -$12.5M -$2.56M Oct 1, 2011 Dec 31, 2011 10-K 2014-03-10
Q3 2011 -$3.21M +$719K +18.3% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-09
Q2 2011 -$3.65M +$1.3M +26.3% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-09
Q1 2011 -$3.1M Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-09
Q3 2010 -$3.93M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-09
Q2 2010 -$4.95M Apr 1, 2010 Jun 30, 2010 10-Q/A 2011-09-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.